BCMA CAR-T Cell Therapy
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BCMA CAR-T Cell Therapy, covering 2021-10-25 to 2025-09-22. Get the full timeline:
Most recent: Clinical Trial Update: A Single-arm Single-center Trial of Bridging GPRC5D/CD3 Bispecific Antibody Treatment With BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]